Extended-Release Naltrexone Improves Viral Suppression among Incarcerated Persons Living with HIV with Opioid Use Disorders Transitioning to the Community: Results of a Double-Blind, Placebo-Controlled Randomized Trial.

Extended-Release Naltrexone Improves Viral Suppression among Incarcerated Persons Living with HIV with Opioid Use Disorders Transitioning to the Community: Results of a Double-Blind, Placebo-Controlled Randomized Trial.

Item

http://www.wikidata.org/entity/Q47548700

Q47548700

about

Extended-Release Naltrexone Improves Viral Suppression among Incarcerated Persons Living with HIV with Opioid Use Disorders Transitioning to the Community: Results of a Double-Blind, Placebo-Controlled Randomized Trial.

Item

http://www.wikidata.org/entity/Q47548700

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Extended-Release Naltrexone Im ...... o-Controlled Randomized Trial.

@en

Extended-Release Naltrexone Im ...... o-Controlled Randomized Trial.

@nl

type

Item

label

Extended-Release Naltrexone Im ...... o-Controlled Randomized Trial.

@en

Extended-Release Naltrexone Im ...... o-Controlled Randomized Trial.

@nl

prefLabel

Extended-Release Naltrexone Im ...... o-Controlled Randomized Trial.

@en

Extended-Release Naltrexone Im ...... o-Controlled Randomized Trial.

@nl

P1476

Extended-Release Naltrexone Im ...... bo-Controlled Randomized Trial

@en

P2093

Angela Di Paola

http://www.w3.org/2001/XMLSchema#string

Breanne E Biondi

http://www.w3.org/2001/XMLSchema#string

Daniel J Skiest

http://www.w3.org/2001/XMLSchema#string

Marwan M Azar

http://www.w3.org/2001/XMLSchema#string

Maureen Desabrais

http://www.w3.org/2001/XMLSchema#string

Russell Barbour

http://www.w3.org/2001/XMLSchema#string

Sandra A Springer

http://www.w3.org/2001/XMLSchema#string

P2860

A randomised controlled trial comparing computer-assisted with face-to-face sexual history taking in a clinical setting

Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II

Note on the sampling error of the difference between correlated proportions or percentages

Retention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisoners

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10

Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders.

HIV/AIDS among inmates of and releasees from US correctional facilities, 2006: declining share of epidemic but persistent public health opportunity.

What impact do assumptions about missing data have on conclusions? A practical sensitivity analysis for a cancer survival registry.

An evaluation of hepatic enzyme elevations among HIV-infected released prisoners enrolled in two randomized placebo-controlled trials of extended release naltrexone.

Release from prison--a high risk of death for former inmates.

P304

43-53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAI.0000000000001634

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Thomas Lincoln

Frederick L Altice

P577

2018-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29373393

http://www.w3.org/2001/XMLSchema#string

P921

placebo

naltrexone

P932

5889326

http://www.w3.org/2001/XMLSchema#string

Extended-Release Naltrexone Improves Viral Suppression among Incarcerated Persons Living with HIV with Opioid Use Disorders Transitioning to the Community: Results of a Double-Blind, Placebo-Controlled Randomized Trial.

about

Extended-Release Naltrexone Improves Viral Suppression among Incarcerated Persons Living with HIV with Opioid Use Disorders Transitioning to the Community: Results of a Double-Blind, Placebo-Controlled Randomized Trial.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932